Literature DB >> 11127264

UK NEQAS in antibiotic assays.

L O White1.   

Abstract

How providers of external quality assessment (EQA) programmes relate to and interact with the monitors and watchdog of clinical laboratory performance in the UK is described. With regard to the quality of antibiotic assays, the changes in methodologies and in performance quality between 1971 (when the UK NEQAS for Antibiotic Assays began) and 1999 is reviewed. How improvements in performance and changes of methodology are related is discussed. The findings and conclusions of two experimental pilot EQA distributions (the teicoplanin assay and serum bactericidal test) are also discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127264      PMCID: PMC1731118          DOI: 10.1136/jcp.53.11.829

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Assays for therapeutic monitoring and pharmacokinetic investigations of aminoglycosides: quality aspects.

Authors:  L O White
Journal:  Ther Drug Monit       Date:  1998-10       Impact factor: 3.681

2.  The quality of clinical serum teicoplanin assays: an experimental European EQA distribution.

Authors:  L O White; C McMullin; A J Davis; A P MacGowan; I Harding; D S Reeves
Journal:  J Antimicrob Chemother       Date:  1996-10       Impact factor: 5.790

3.  Estimation of serum gentamicin by quenching fluoroimmunoassay.

Authors:  E J Shaw; R A Watson; J Landon; D S Smith
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

4.  External quality assessment of the serum bactericidal test: results of a methodology/interpretation questionnaire.

Authors:  A MacGowan; C McMullin; P James; K Bowker; D Reeves; L White
Journal:  J Antimicrob Chemother       Date:  1997-02       Impact factor: 5.790

Review 5.  Therapeutic drug monitoring of systemic antifungal therapy.

Authors:  K K Summers; T C Hardin; S J Gore; J R Graybill
Journal:  J Antimicrob Chemother       Date:  1997-12       Impact factor: 5.790

6.  Homogeneous reactant-labeled fluorescent immunoassay for therapeutic drugs exemplified by gentamicin determination in human serum.

Authors:  J F Burd; R C Wong; J E Feeney; R J Carrico; R C Boguslaski
Journal:  Clin Chem       Date:  1977-08       Impact factor: 8.327

7.  A comparative survey of the results of analyses of blood serum in clinical chemistry laboratories in the United Kingdom.

Authors:  T P Whitehead; D M Browning; A Gregory
Journal:  J Clin Pathol       Date:  1973-06       Impact factor: 3.411

8.  Therapeutic monitoring of antimicrobials: a summary of the information presented at the UK NEQAS for antibiotic Assays meeting for participants, October 1993.

Authors:  D S Reeves; A P MacGowan; H A Holt; A M Lovering; D W Warnock; L O White
Journal:  J Antimicrob Chemother       Date:  1995-01       Impact factor: 5.790

9.  Quality control of serum gentamicin assays--experience of national surveys.

Authors:  D S Reeves; M J Bywater
Journal:  J Antimicrob Chemother       Date:  1975-03       Impact factor: 5.790

  9 in total
  1 in total

1.  Accuracy of Different Bioinformatics Methods in Detecting Antibiotic Resistance and Virulence Factors from Staphylococcus aureus Whole-Genome Sequences.

Authors:  Amy Mason; Dona Foster; Phelim Bradley; Tanya Golubchik; Michel Doumith; A Sarah Walker; Angela Kearns; Tim Peto; N Claire Gordon; Bruno Pichon; Zamin Iqbal; Peter Staves; Derrick Crook
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.